BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 24008728)

  • 1. IAPs on the move: role of inhibitors of apoptosis proteins in cell migration.
    Oberoi-Khanuja TK; Murali A; Rajalingam K
    Cell Death Dis; 2013 Sep; 4(9):e784. PubMed ID: 24008728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IAPs as E3 ligases of Rac1: shaping the move.
    Oberoi-Khanuja TK; Rajalingam K
    Small GTPases; 2012; 3(2):131-6. PubMed ID: 22790203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IAPs regulate the plasticity of cell migration by directly targeting Rac1 for degradation.
    Oberoi TK; Dogan T; Hocking JC; Scholz RP; Mooz J; Anderson CL; Karreman C; Meyer zu Heringdorf D; Schmidt G; Ruonala M; Namikawa K; Harms GS; Carpy A; Macek B; Köster RW; Rajalingam K
    EMBO J; 2012 Jan; 31(1):14-28. PubMed ID: 22117219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IAPs: more than just inhibitors of apoptosis proteins.
    Dubrez-Daloz L; Dupoux A; Cartier J
    Cell Cycle; 2008 Apr; 7(8):1036-46. PubMed ID: 18414036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitor of apoptosis proteins as E3 ligases for ubiquitin and NEDD8.
    Kamada S
    Biomol Concepts; 2013 Apr; 4(2):161-71. PubMed ID: 25436573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IAPs and cell migration.
    Dubrez L; Rajalingam K
    Semin Cell Dev Biol; 2015 Mar; 39():124-31. PubMed ID: 25769935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based design and molecular profiling of Smac-mimetics selective for cellular IAPs.
    Corti A; Milani M; Lecis D; Seneci P; de Rosa M; Mastrangelo E; Cossu F
    FEBS J; 2018 Sep; 285(17):3286-3298. PubMed ID: 30055105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular inhibitor of apoptosis protein 1 ubiquitinates endonuclease G but does not affect endonuclease G-mediated cell death.
    Seo TW; Lee JS; Yoo SJ
    Biochem Biophys Res Commun; 2014 Sep; 451(4):644-9. PubMed ID: 25139236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ubiquitination of Rac1 by inhibitors of apoptosis (IAPs).
    Oberoi-Khanuja TK; Rajalingam K
    Methods Mol Biol; 2014; 1120():43-54. PubMed ID: 24470018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different Degradation Mechanisms of Inhibitor of Apoptosis Proteins (IAPs) by the Specific and Nongenetic IAP-Dependent Protein Eraser (SNIPER).
    Ohoka N; Ujikawa O; Shimokawa K; Sameshima T; Shibata N; Hattori T; Nara H; Cho N; Naito M
    Chem Pharm Bull (Tokyo); 2019 Mar; 67(3):203-209. PubMed ID: 30369550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitor of apoptosis proteins as intracellular signaling intermediates.
    Kocab AJ; Duckett CS
    FEBS J; 2016 Jan; 283(2):221-31. PubMed ID: 26462035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique BIR domain sets determine inhibitor of apoptosis protein-driven cell death and NOD2 complex signal specificity.
    Chirieleison SM; Rathkey JK; Abbott DW
    Sci Signal; 2018 Jul; 11(539):. PubMed ID: 30018081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The RING domain of cIAP1 mediates the degradation of RING-bearing inhibitor of apoptosis proteins by distinct pathways.
    Cheung HH; Plenchette S; Kern CJ; Mahoney DJ; Korneluk RG
    Mol Biol Cell; 2008 Jul; 19(7):2729-40. PubMed ID: 18434593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The IAP family: endogenous caspase inhibitors with multiple biological activities.
    Yang YL; Li XM
    Cell Res; 2000 Sep; 10(3):169-77. PubMed ID: 11032169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitor of apoptosis proteins as novel targets in inflammatory processes.
    Mayer BA; Rehberg M; Erhardt A; Wolf A; Reichel CA; Kracht M; Krombach F; Tiegs G; Zahler S; Vollmar AM; Fürst R
    Arterioscler Thromb Vasc Biol; 2011 Oct; 31(10):2240-50. PubMed ID: 21817100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular inhibitors of apoptosis are global regulators of NF-κB and MAPK activation by members of the TNF family of receptors.
    Varfolomeev E; Goncharov T; Maecker H; Zobel K; Kömüves LG; Deshayes K; Vucic D
    Sci Signal; 2012 Mar; 5(216):ra22. PubMed ID: 22434933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Multiple Roles of the IAP Super-family in cancer.
    Kumar S; Fairmichael C; Longley DB; Turkington RC
    Pharmacol Ther; 2020 Oct; 214():107610. PubMed ID: 32585232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IAP proteins: regulators of cell migration and development.
    Kenneth NS; Duckett CS
    Curr Opin Cell Biol; 2012 Dec; 24(6):871-5. PubMed ID: 23219152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of inhibitor of apoptosis proteins on immune modulation and inflammation.
    Sharma S; Kaufmann T; Biswas S
    Immunol Cell Biol; 2017 Mar; 95(3):236-243. PubMed ID: 27713393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors of apoptosis proteins (IAPs) as potential molecular targets for therapy of hematological malignancies.
    Smolewski P; Robak T
    Curr Mol Med; 2011 Nov; 11(8):633-49. PubMed ID: 21902653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.